{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:10:59Z","timestamp":1790107859565,"version":"4.0.1"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:00:00Z","timestamp":1723852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:00:00Z","timestamp":1723852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-024-02047-x","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T05:02:30Z","timestamp":1723870950000},"page":"2127-2138","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Biomarkers in cardiorenal syndrome, a potential use in precision medicine"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8645-2102","authenticated-orcid":false,"given":"Eleni","family":"Stefanou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Tountas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Ioannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4695-3723","authenticated-orcid":false,"given":"Christo","family":"Kole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,17]]},"reference":[{"issue":"23","key":"2047_CR1","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1161\/CIRCULATIONAHA.109.886473","volume":"121","author":"JS Bock","year":"2010","unstructured":"Bock JS, Gottlieb SS (2010) Cardiorenal syndrome: new perspectives. Circulation 121(23):2592\u20132600. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.886473","journal-title":"Circulation"},{"issue":"7","key":"2047_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","volume":"35","author":"K Damman","year":"2014","unstructured":"Damman K, Valente MA, Voors AA et al (2014) Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J 35(7):455\u2013469. https:\/\/doi.org\/10.1093\/eurheartj\/eht386","journal-title":"Eur Heart J"},{"issue":"11","key":"2047_CR3","doi-asserted-by":"publisher","first-page":"5550","DOI":"10.1073\/pnas.2001336117","volume":"117","author":"PL Tharaux","year":"2020","unstructured":"Tharaux PL (2020) Histamine provides an original vista on cardiorenal syndrome. Proc Natl Acad Sci USA 117(11):5550\u20135552. https:\/\/doi.org\/10.1073\/pnas.2001336117","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2047_CR4","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/eurheartj\/ehi859","volume":"27","author":"MR Cowie","year":"2006","unstructured":"Cowie MR, Komajda M, Murray-Thomas T et al (2006) Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J 27(10):1216\u20131222. https:\/\/doi.org\/10.1093\/eurheartj\/ehi859","journal-title":"Eur Heart J"},{"issue":"10","key":"2047_CR5","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/j.jacc.2005.11.084","volume":"47","author":"GL Smith","year":"2006","unstructured":"Smith GL, Lichtman JH, Bracken MB et al (2006) Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 47(10):1987\u20131996. https:\/\/doi.org\/10.1016\/j.jacc.2005.11.084","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2047_CR6","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1093\/ndt\/gfq066","volume":"25","author":"SM Bagshaw","year":"2010","unstructured":"Bagshaw SM, Cruz DN, Aspromonte N et al (2010) Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI consensus conference. Nephrol Dial Transplant 25(5):1406\u20131416. https:\/\/doi.org\/10.1093\/ndt\/gfq066","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"2047_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.cardfail.2007.04.008","volume":"13","author":"K Damman","year":"2007","unstructured":"Damman K, Navis G, Voors AA et al (2007) Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail 13(8):599\u2013608. https:\/\/doi.org\/10.1016\/j.cardfail.2007.04.008","journal-title":"J Card Fail"},{"issue":"2","key":"2047_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10741-011-9246-2","volume":"17","author":"B Braam","year":"2012","unstructured":"Braam B, Cupples WA, Joles JA, Gaillard C (2012) Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure. Heart Fail Rev 17(2):161\u2013175. https:\/\/doi.org\/10.1007\/s10741-011-9246-2","journal-title":"Heart Fail Rev"},{"issue":"1","key":"2047_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000335499","volume":"2","author":"GM Virzi","year":"2012","unstructured":"Virzi GM, Torregrossa R, Cruz DN et al (2012) Cardiorenal syndrome type 1 may be immunologically mediated: a pilot evaluation of monocyte apoptosis. Cardiorenal Med 2(1):33\u201342. https:\/\/doi.org\/10.1159\/000335499","journal-title":"Cardiorenal Med"},{"issue":"8","key":"2047_CR10","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.hlc.2016.02.022","volume":"25","author":"B Giam","year":"2016","unstructured":"Giam B, Kaye DM, Rajapakse NW (2016) Role of renal oxidative stress in the pathogenesis of the cardiorenal syndrome. Heart Lung Circ 25(8):874\u2013880. https:\/\/doi.org\/10.1016\/j.hlc.2016.02.022","journal-title":"Heart Lung Circ"},{"issue":"1","key":"2047_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.semnephrol.2011.11.004","volume":"32","author":"P Jois","year":"2012","unstructured":"Jois P, Mebazaa A (2012) Cardio-renal syndrome type 2: epidemiology, pathophysiology, and treatment. Semin Nephrol 32(1):26\u201330. https:\/\/doi.org\/10.1016\/j.semnephrol.2011.11.004","journal-title":"Semin Nephrol"},{"key":"2047_CR12","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/351291","volume":"2011","author":"DN Cruz","year":"2010","unstructured":"Cruz DN, Bagshaw SM (2010) Heart-kidney interaction: epidemiology of cardiorenal syndromes. Int J Nephrol 2011:351291. https:\/\/doi.org\/10.4061\/2011\/351291","journal-title":"Int J Nephrol"},{"issue":"15","key":"2047_CR13","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.jacc.2007.12.035","volume":"51","author":"PA McCullough","year":"2008","unstructured":"McCullough PA (2008) Contrast-induced acute kidney injury. J Am Coll Cardiol 51(15):1419\u20131428. https:\/\/doi.org\/10.1016\/j.jacc.2007.12.035","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2047_CR14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1056\/NEJMoa051530","volume":"355","author":"RS Bhatia","year":"2006","unstructured":"Bhatia RS, Tu JV, Lee DS et al (2006) Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355(3):260\u2013269. https:\/\/doi.org\/10.1056\/NEJMoa051530","journal-title":"N Engl J Med"},{"issue":"5","key":"2047_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/0002-9343(46)90067-8","volume":"1","author":"AJ Merrill","year":"1946","unstructured":"Merrill AJ, Morrison JL, Branno ES (1946) Concentration of renin in renal venous blood in patients with chronic heart failure. Am J Med 1(5):468. https:\/\/doi.org\/10.1016\/0002-9343(46)90067-8","journal-title":"Am J Med"},{"issue":"2","key":"2047_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ihj.2017.01.005","volume":"69","author":"L Di Lullo","year":"2017","unstructured":"Di Lullo L, Bellasi A, Barbera V et al (2017) Pathophysiology of the cardio-renal syndromes types 1\u20135: an uptodate. Indian Heart J 69(2):255\u2013265. https:\/\/doi.org\/10.1016\/j.ihj.2017.01.005","journal-title":"Indian Heart J"},{"issue":"8","key":"2047_CR17","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1681\/ASN.2007101079","volume":"19","author":"G Remuzzi","year":"2008","unstructured":"Remuzzi G, Cattaneo D, Perico N (2008) The aggravating mechanisms of aldosterone on kidney fibrosis. J Am Soc Nephrol 19(8):1459\u20131462. https:\/\/doi.org\/10.1681\/ASN.2007101079","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2047_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.semnephrol.2011.11.005","volume":"32","author":"A Chuasuwan","year":"2012","unstructured":"Chuasuwan A, Kellum JA (2012) Cardio-renal syndrome type 3: epidemiology, pathophysiology, and treatment. Semin Nephrol 32(1):31\u201339. https:\/\/doi.org\/10.1016\/j.semnephrol.2011.11.005","journal-title":"Semin Nephrol"},{"issue":"1","key":"2047_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000074934","volume":"22","author":"PA McCullough","year":"2004","unstructured":"McCullough PA, Sandberg KR (2004) Chronic kidney disease and sudden death: strategies for prevention. Blood Purif 22(1):136\u2013142. https:\/\/doi.org\/10.1159\/000074934","journal-title":"Blood Purif"},{"issue":"4","key":"2047_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1046\/j.1525-139x.2000.00068.x","volume":"13","author":"JP Brady","year":"2000","unstructured":"Brady JP, Hasbargen JA (2000) A review of the effects of correction of acidosis on nutrition in dialysis patients. Semin Dial 13(4):252\u2013255. https:\/\/doi.org\/10.1046\/j.1525-139x.2000.00068.x","journal-title":"Semin Dial"},{"issue":"5","key":"2047_CR21","doi-asserted-by":"publisher","first-page":"M911","DOI":"10.1097\/00002480-199609000-00127","volume":"42","author":"P Blake","year":"1996","unstructured":"Blake P, Hasegawa Y, Khosla MC et al (1996) Isolation of \u201cmyocardial depressant factor(s)\u201d from the ultrafiltrate of heart failure patients with acute renal failure. ASAIO J 42(5):M911\u2013M915. https:\/\/doi.org\/10.1097\/00002480-199609000-00127","journal-title":"ASAIO J"},{"key":"2047_CR22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000349972","volume":"182","author":"JA Tumlin","year":"2013","unstructured":"Tumlin JA, Costanzo MR, Chawla LS et al (2013) Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 182:158\u2013173. https:\/\/doi.org\/10.1159\/000349972","journal-title":"Contrib Nephrol"},{"issue":"4","key":"2047_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000471813","volume":"7","author":"G Cianciolo","year":"2017","unstructured":"Cianciolo G, De Pascalis A, Di Lullo L et al (2017) Folic acid and homocysteine in chronic kidney disease and cardiovascular disease progression: which comes first? Cardiorenal Med 7(4):255\u2013266. https:\/\/doi.org\/10.1159\/000471813","journal-title":"Cardiorenal Med"},{"issue":"6","key":"2047_CR24","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/MCC.0b013e328332f69e","volume":"15","author":"X Li","year":"2009","unstructured":"Li X, Hassoun HT, Santora R, Rabb H (2009) Organ crosstalk: the role of the kidney. Curr Opin Crit Care 15(6):481\u2013487. https:\/\/doi.org\/10.1097\/MCC.0b013e328332f69e","journal-title":"Curr Opin Crit Care"},{"issue":"4","key":"2047_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000444502","volume":"83","author":"GM Virzi","year":"2016","unstructured":"Virzi GM, Clementi A, Brocca A, de Cal M, Ronco C (2016) Molecular and genetic mechanisms involved in the pathogenesis of cardiorenal cross talk. Pathobiology 83(4):201\u2013210. https:\/\/doi.org\/10.1159\/000444502","journal-title":"Pathobiology"},{"key":"2047_CR26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000349970","volume":"182","author":"RL Mehta","year":"2013","unstructured":"Mehta RL, Rabb H, Shaw AD et al (2013) Cardiorenal syndrome type 5: clinical presentation, pathophysiology and management strategies from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 182:174\u2013194. https:\/\/doi.org\/10.1159\/000349970","journal-title":"Contrib Nephrol"},{"issue":"4","key":"2047_CR27","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A (2012) KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 120(4):c179\u2013c184","journal-title":"Nephron Clin Pract"},{"issue":"7","key":"2047_CR28","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.41252","volume":"15","author":"AO Ajibowo","year":"2023","unstructured":"Ajibowo AO, Okobi OE, Emore E et al (2023) Cardiorenal syndrome: a literature review. Cureus 15(7):e41252. https:\/\/doi.org\/10.7759\/cureus.41252","journal-title":"Cureus"},{"issue":"9689","key":"2047_CR29","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0140-6736(09)61378-7","volume":"374","author":"CE Jackson","year":"2009","unstructured":"Jackson CE, Solomon SD, Gerstein HC et al (2009) Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet 374(9689):543\u2013550. https:\/\/doi.org\/10.1016\/S0140-6736(09)61378-7","journal-title":"Lancet"},{"issue":"11","key":"2047_CR30","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.cardfail.2022.09.002","volume":"28","author":"NE Landler","year":"2022","unstructured":"Landler NE, Olsen FJ, Christensen J et al (2022) Associations between albuminuria, estimated GFR and cardiac phenotype in a cohort with chronic kidney disease: the CPH-CKD ECHO study. J Card Fail 28(11):1615\u20131627. https:\/\/doi.org\/10.1016\/j.cardfail.2022.09.002","journal-title":"J Card Fail"},{"issue":"4","key":"2047_CR31","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1002\/ehf2.13399","volume":"8","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhao X, Zhai M et al (2021) Elevated urinary albumin concentration predicts worse clinical outcomes in hospitalized acute decompensated heart failure patients. ESC Heart Fail 8(4):3037\u20133048. https:\/\/doi.org\/10.1002\/ehf2.13399","journal-title":"ESC Heart Fail"},{"issue":"4","key":"2047_CR32","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1093\/ndt\/gfl744","volume":"22","author":"D Singh","year":"2007","unstructured":"Singh D, Whooley MA, Ix JH, Ali S, Shlipak MG (2007) Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial Transplant 22(4):1087\u20131092. https:\/\/doi.org\/10.1093\/ndt\/gfl744","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"2047_CR33","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/ki.2008.638","volume":"75","author":"LA Stevens","year":"2009","unstructured":"Stevens LA, Schmid CH, Greene T et al (2009) Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 75(6):652\u2013660. https:\/\/doi.org\/10.1038\/ki.2008.638","journal-title":"Kidney Int"},{"issue":"5","key":"2047_CR34","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1046\/j.1523-1755.2003.00925.x","volume":"63","author":"M Fricker","year":"2003","unstructured":"Fricker M, Wiesli P, Brandle M, Schwegler B, Schmid C (2003) Impact of thyroid dysfunction on serum cystatin C. Kidney Int 63(5):1944\u20131947. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00925.x","journal-title":"Kidney Int"},{"key":"2047_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cca.2018.10.022","volume":"487","author":"Y Nozawa","year":"2018","unstructured":"Nozawa Y, Sato H, Wakamatsu A et al (2018) Utility of estimated glomerular filtration rate using cystatin C and its interpretation in patients with rheumatoid arthritis under glucocorticoid therapy. Clin Chim Acta 487:299\u2013305. https:\/\/doi.org\/10.1016\/j.cca.2018.10.022","journal-title":"Clin Chim Acta"},{"key":"2047_CR36","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20181761","author":"S Chen","year":"2019","unstructured":"Chen S, Tang Y, Zhou X (2019) Cystatin C for predicting all-cause mortality and rehospitalization in patients with heart failure: a meta-analysis. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20181761"},{"key":"2047_CR37","doi-asserted-by":"publisher","first-page":"41012","DOI":"10.1038\/srep41012","volume":"7","author":"Z Yong","year":"2017","unstructured":"Yong Z, Pei X, Zhu B, Yuan H, Zhao W (2017) Predictive value of serum cystatin C for acute kidney injury in adults: a meta-analysis of prospective cohort trials. Sci Rep 7:41012. https:\/\/doi.org\/10.1038\/srep41012","journal-title":"Sci Rep"},{"issue":"10","key":"2047_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002400","volume":"14","author":"A Shardlow","year":"2017","unstructured":"Shardlow A, McIntyre NJ, Fraser SDS et al (2017) The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: a primary care cohort study. PLoS Med 14(10):e1002400. https:\/\/doi.org\/10.1371\/journal.pmed.1002400","journal-title":"PLoS Med"},{"issue":"5","key":"2047_CR39","first-page":"404","volume":"19","author":"ZB Ruan","year":"2014","unstructured":"Ruan ZB, Zhu L, Yin YG, Chen GC (2014) Cystatin C, N-terminal probrain natriuretic peptides and outcomes in acute heart failure with acute kidney injury in a 12-month follow-up: Insights into the cardiorenal syndrome. J Res Med Sci 19(5):404\u2013409","journal-title":"J Res Med Sci"},{"key":"2047_CR40","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ijcard.2014.12.135","volume":"182","author":"P Rafouli-Stergiou","year":"2015","unstructured":"Rafouli-Stergiou P, Parissis J, Farmakis D et al (2015) Prognostic value of in-hospital change in cystatin C in patients with acutely decompensated heart failure and renal dysfunction. Int J Cardiol 182:74\u201376. https:\/\/doi.org\/10.1016\/j.ijcard.2014.12.135","journal-title":"Int J Cardiol"},{"issue":"7","key":"2047_CR41","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1074\/jbc.273.7.4135","volume":"273","author":"T Ichimura","year":"1998","unstructured":"Ichimura T, Bonventre JV, Bailly V et al (1998) Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 273(7):4135\u20134142. https:\/\/doi.org\/10.1074\/jbc.273.7.4135","journal-title":"J Biol Chem"},{"issue":"1","key":"2047_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12967-021-02776-8","volume":"19","author":"J Geng","year":"2021","unstructured":"Geng J, Qiu Y, Qin Z, Su B (2021) The value of kidney injury molecule 1 in predicting acute kidney injury in adult patients: a systematic review and Bayesian meta-analysis. J Transl Med 19(1):105. https:\/\/doi.org\/10.1186\/s12967-021-02776-8","journal-title":"J Transl Med"},{"issue":"10","key":"2047_CR43","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/ki.2010.555","volume":"79","author":"ZH Endre","year":"2011","unstructured":"Endre ZH, Pickering JW, Walker RJ et al (2011) Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int 79(10):1119\u20131130. https:\/\/doi.org\/10.1038\/ki.2010.555","journal-title":"Kidney Int"},{"issue":"16","key":"2047_CR44","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1136\/hrt.2010.194878","volume":"96","author":"K Damman","year":"2010","unstructured":"Damman K, Van Veldhuisen DJ, Navis G et al (2010) Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart 96(16):1297\u20131302. https:\/\/doi.org\/10.1136\/hrt.2010.194878","journal-title":"Heart"},{"issue":"11","key":"2047_CR45","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.26355\/eurrev_201806_15180","volume":"22","author":"A Atici","year":"2018","unstructured":"Atici A, Emet S, Cakmak R et al (2018) Type I cardiorenal syndrome in patients with acutely decompensated heart failure: the importance of new renal biomarkers. Eur Rev Med Pharmacol Sci 22(11):3534\u20133543. https:\/\/doi.org\/10.26355\/eurrev_201806_15180","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"2047_CR46","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/1076029617729216","volume":"24","author":"R McMillan","year":"2018","unstructured":"McMillan R, Skiadopoulos L, Hoppensteadt D et al (2018) Biomarkers of endothelial, renal, and platelet dysfunction in stage 5 chronic kidney disease hemodialysis patients with heart failure. Clin Appl Thromb Hemost 24(2):235\u2013240. https:\/\/doi.org\/10.1177\/1076029617729216","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2","key":"2047_CR47","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1681\/ASN.2006080882","volume":"18","author":"KM Schmidt-Ott","year":"2007","unstructured":"Schmidt-Ott KM, Mori K, Li JY et al (2007) Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 18(2):407\u2013413. https:\/\/doi.org\/10.1681\/ASN.2006080882","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2047_CR48","doi-asserted-by":"publisher","first-page":"R127","DOI":"10.1186\/cc6192","volume":"11","author":"CL Dent","year":"2007","unstructured":"Dent CL, Ma Q, Dastrala S et al (2007) Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 11(6):R127. https:\/\/doi.org\/10.1186\/cc6192","journal-title":"Crit Care"},{"issue":"6","key":"2047_CR49","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/ejhf.746","volume":"19","author":"M Sokolski","year":"2017","unstructured":"Sokolski M, Zymlinski R, Biegus J et al (2017) Urinary levels of novel kidney biomarkers and risk of true worsening renal function and mortality in patients with acute heart failure. Eur J Heart Fail 19(6):760\u2013767. https:\/\/doi.org\/10.1002\/ejhf.746","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"2047_CR50","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.2215\/CJN.00910116","volume":"11","author":"C Chen","year":"2016","unstructured":"Chen C, Yang X, Lei Y et al (2016) Urinary biomarkers at the time of AKI diagnosis as predictors of progression of AKI among patients with acute cardiorenal syndrome. Clin J Am Soc Nephrol 11(9):1536\u20131544. https:\/\/doi.org\/10.2215\/CJN.00910116","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"2047_CR51","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.cardfail.2013.07.004","volume":"19","author":"FH Verbrugge","year":"2013","unstructured":"Verbrugge FH, Dupont M, Shao Z et al (2013) Novel urinary biomarkers in detecting acute kidney injury, persistent renal impairment, and all-cause mortality following decongestive therapy in acute decompensated heart failure. J Card Fail 19(9):621\u2013628. https:\/\/doi.org\/10.1016\/j.cardfail.2013.07.004","journal-title":"J Card Fail"},{"issue":"9","key":"2047_CR52","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2459\/JCM.0b013e3283629ca6","volume":"14","author":"A Mortara","year":"2013","unstructured":"Mortara A, Bonadies M, Mazzetti S et al (2013) Neutrophil gelatinase-associated lipocalin predicts worsening of renal function in acute heart failure: methodological and clinical issues. J Cardiovasc Med (Hagerstown) 14(9):629\u2013634. https:\/\/doi.org\/10.2459\/JCM.0b013e3283629ca6","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"3","key":"2047_CR53","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2215\/CJN.06140710","volume":"6","author":"M Alvelos","year":"2011","unstructured":"Alvelos M, Pimentel R, Pinho E et al (2011) Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward. Clin J Am Soc Nephrol 6(3):476\u2013481. https:\/\/doi.org\/10.2215\/CJN.06140710","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"2047_CR54","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1053\/j.ajkd.2009.07.020","volume":"54","author":"M Haase","year":"2009","unstructured":"Haase M, Bellomo R, Devarajan P et al (2009) Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 54(6):1012\u20131024. https:\/\/doi.org\/10.1053\/j.ajkd.2009.07.020","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"2047_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095254","volume":"9","author":"YH Lin","year":"2014","unstructured":"Lin YH, Chou CH, Wu XM et al (2014) Aldosterone induced galectin-3 secretion in vitro and in vivo: from cells to humans. PLoS ONE 9(9):e95254. https:\/\/doi.org\/10.1371\/journal.pone.0095254","journal-title":"PLoS ONE"},{"issue":"6","key":"2047_CR56","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jacc.2006.03.061","volume":"48","author":"RR van Kimmenade","year":"2006","unstructured":"van Kimmenade RR, Januzzi JL Jr, Ellinor PT et al (2006) Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol 48(6):1217\u20131224. https:\/\/doi.org\/10.1016\/j.jacc.2006.03.061","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2047_CR57","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00392-010-0125-y","volume":"99","author":"DJ Lok","year":"2010","unstructured":"Lok DJ, Van Der Meer P, de la Porte PW et al (2010) Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clin Res Cardiol 99(5):323\u2013328. https:\/\/doi.org\/10.1007\/s00392-010-0125-y","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"2047_CR58","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.112.000760","volume":"1","author":"DM Gopal","year":"2012","unstructured":"Gopal DM, Kommineni M, Ayalon N et al (2012) Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure. J Am Heart Assoc 1(5):e000760. https:\/\/doi.org\/10.1161\/JAHA.112.000760","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"2047_CR59","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2217\/bmm-2018-0349","volume":"13","author":"M Iacoviello","year":"2019","unstructured":"Iacoviello M, Di Serio F, Rizzo C et al (2019) Association between high Gal-3 serum levels and worsening of renal function in chronic heart failure outpatients. Biomark Med 13(9):707\u2013713. https:\/\/doi.org\/10.2217\/bmm-2018-0349","journal-title":"Biomark Med"},{"issue":"1","key":"2047_CR60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13054-021-03878-x","volume":"26","author":"L Boutin","year":"2022","unstructured":"Boutin L, Legrand M, Sadoune M et al (2022) Elevated plasma galectin-3 is associated with major adverse kidney events and death after ICU admission. Crit Care 26(1):13. https:\/\/doi.org\/10.1186\/s13054-021-03878-x","journal-title":"Crit Care"},{"issue":"6","key":"2047_CR61","doi-asserted-by":"publisher","first-page":"862","DOI":"10.6515\/ACS.202311_39(6).20230903A","volume":"39","author":"S Ozyildirim","year":"2023","unstructured":"Ozyildirim S, Dogan O, Barman HA et al (2023) Galectin-3 as a biomarker to predict cardiorenal syndrome in patients with acute heart failure. Acta Cardiol Sin 39(6):862\u2013870. https:\/\/doi.org\/10.6515\/ACS.202311_39(6).20230903A","journal-title":"Acta Cardiol Sin"},{"issue":"23","key":"2047_CR62","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1161\/01.cir.0000038705.69871.d9","volume":"106","author":"EO Weinberg","year":"2002","unstructured":"Weinberg EO, Shimpo M, De Keulenaer GW et al (2002) Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 106(23):2961\u20132966. https:\/\/doi.org\/10.1161\/01.cir.0000038705.69871.d9","journal-title":"Circulation"},{"issue":"7","key":"2047_CR63","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jacc.2007.05.014","volume":"50","author":"JL Januzzi Jr","year":"2007","unstructured":"Januzzi JL Jr, Peacock WF, Maisel AS et al (2007) Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J Am Coll Cardiol 50(7):607\u2013613. https:\/\/doi.org\/10.1016\/j.jacc.2007.05.014","journal-title":"J Am Coll Cardiol"},{"key":"2047_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2021.100887","volume":"37","author":"C Ip","year":"2021","unstructured":"Ip C, Luk KS, Yuen VLC et al (2021) Soluble suppression of tumorigenicity 2 (sST2) for predicting disease severity or mortality outcomes in cardiovascular diseases: a systematic review and meta-analysis. Int J Cardiol Heart Vasc 37:100887. https:\/\/doi.org\/10.1016\/j.ijcha.2021.100887","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"4","key":"2047_CR65","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1161\/CIRCHEARTFAILURE.108.833707","volume":"2","author":"RV Shah","year":"2009","unstructured":"Shah RV, Chen-Tournoux AA, Picard MH, van Kimmenade RR, Januzzi JL (2009) Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea. Circ Heart Fail 2(4):311\u2013319. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.108.833707","journal-title":"Circ Heart Fail"},{"key":"2047_CR66","doi-asserted-by":"publisher","first-page":"3952526","DOI":"10.1155\/2018\/3952526","volume":"2018","author":"M Plawecki","year":"2018","unstructured":"Plawecki M, Morena M, Kuster N et al (2018) sST2 as a new biomarker of chronic kidney disease-induced cardiac remodeling: impact on risk prediction. Mediators Inflamm 2018:3952526. https:\/\/doi.org\/10.1155\/2018\/3952526","journal-title":"Mediators Inflamm"},{"issue":"4","key":"2047_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125282","volume":"10","author":"YC Tung","year":"2015","unstructured":"Tung YC, Chang CH, Chen YC, Chu PH (2015) Combined biomarker analysis for risk of acute kidney injury in patients with ST-segment elevation myocardial infarction. PLoS ONE 10(4):e0125282. https:\/\/doi.org\/10.1371\/journal.pone.0125282","journal-title":"PLoS ONE"},{"issue":"5","key":"2047_CR68","doi-asserted-by":"publisher","first-page":"E584","DOI":"10.59958\/hsf.6669","volume":"26","author":"Y Hua","year":"2023","unstructured":"Hua Y, Zhang W, Li X (2023) The value of soluble ST2 in predicting cardiorenal syndrome type 1 in acute myocardial infarction patients. Heart Surg Forum 26(5):E584\u2013E591. https:\/\/doi.org\/10.59958\/hsf.6669","journal-title":"Heart Surg Forum"},{"issue":"1","key":"2047_CR69","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/cc12503","volume":"17","author":"K Kashani","year":"2013","unstructured":"Kashani K, Al-Khafaji A, Ardiles T et al (2013) Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 17(1):R25. https:\/\/doi.org\/10.1186\/cc12503","journal-title":"Crit Care"},{"issue":"1","key":"2047_CR70","doi-asserted-by":"publisher","first-page":"6037","DOI":"10.1038\/s41598-023-33233-9","volume":"13","author":"F Huang","year":"2023","unstructured":"Huang F, Zeng Y, Lv L et al (2023) Predictive value of urinary cell cycle arrest biomarkers for all cause-acute kidney injury: a meta-analysis. Sci Rep 13(1):6037. https:\/\/doi.org\/10.1038\/s41598-023-33233-9","journal-title":"Sci Rep"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02047-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-024-02047-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02047-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:53:24Z","timestamp":1777564404000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/37\/8\/2127\/8306264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,17]]},"references-count":70,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["2047"],"URL":"https:\/\/doi.org\/10.1007\/s40620-024-02047-x","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,17]]},"assertion":[{"value":"15 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u0395leni Stefanou declares that she has no conflict of interest. Christos Tountas declares that he has no conflict of interest. Emmanouil Ioannidis declares that he has no conflict of interest. Christo Kole declares that he has no conflict of interest. The authors have no competing interests to declare that are relevant to the content of this article. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. The authors have no financial or proprietary interests in any material discussed in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"No human and animal samples were used or analysed in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"This is a review article. No ethical approval is required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This is a review article. No consent is required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This is a review article. No consent is required.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}